Ani Pharmaceuticals Inc (NASDAQ:ANIP) appears in 275 institutional 13F filings for the quarter ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 2,747,492 | 85,780 | 3.22% | $211,282,135.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 823,064 | 823,064 | 0.00% | $63,293,622.00 |
| Soleus Capital Management, L.P. | 31 Mar, 2026 | 820,243 | 334,000 | 68.69% | $63,076,687.00 |
| State Street Corp | 31 Mar, 2026 | 771,587 | 44,383 | 6.10% | $59,335,040.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 707,500 | 226,063 | 46.96% | $54,406,750.00 |
| GOLDENTREE ASSET MANAGEMENT LP | 31 Mar, 2026 | 667,981 | 667,981 | 0.00% | $51,295,618.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 600,000 | 122,316 | 25.61% | $46,140,000.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 592,013 | 52,348 | 9.70% | $45,525,800.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Mar, 2026 | 564,360 | 91,153 | 19.26% | $43,399,284.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 531,190 | 43,523 | 8.92% | $40,842,741.00 |
| UBS Group AG | 31 Mar, 2026 | 497,702 | 346,923 | 230.09% | $38,273,284.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 489,201 | 11,929 | 2.50% | $37,626,432.00 |
| Nuveen, LLC | 31 Mar, 2026 | 402,357 | 15,255 | 3.94% | $30,941,253.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 375,965 | 375,965 | 0.00% | $28,911,709.00 |
| Global Alpha Capital Management Ltd. | 31 Mar, 2026 | 361,240 | -228,895 | -38.79% | $27,779,356.00 |
| Ranger Investment Management, L.P. | 31 Mar, 2026 | 360,083 | -2,295 | -0.63% | $27,690,383.00 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Mar, 2026 | 327,276 | 10,583 | 3.34% | $25,167,524.00 |
| Invesco Ltd. | 31 Mar, 2026 | 324,349 | 134,513 | 70.86% | $24,942,437.00 |
| DEUTSCHE BANK AG\ | 31 Mar, 2026 | 319,675 | -72,901 | -18.57% | $24,583,008.00 |
| Jones Hill Capital LP | 31 Mar, 2026 | 318,591 | 318,591 | 0.00% | $24,499,648.00 |